Hepatocellular carcinoma: is surveillance cost effective?
Bruix
J
J
BCLC Group, Liver Unit, Hospital Clínic IDIBAPS, University of Barcelona, Catalonia, Spain. jbruix@clinic.ub.es
Llovet
J M
JM
D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000191:economics / Q000209:etiology; D003362:Cost-Benefit Analysis; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000191:economics; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000191:economics / Q000209:etiology; D008403:Mass Screening / Q000191:economics*